Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors

被引：101
作者：
Ikegashira, Kazutaka
Oka, Takahiro
Hirashima, Shintaro
Noji, Satoru
Yamanaka, Hiroshi
Hara, Yoshinori
Adachi, Tsuyoshi
Tsuruha, Jun-Ichiro
Doi, Satoki
Hase, Yasunori
Noguchi, Toru
Ando, Izuru
Ogura, Naoki
Ikeda, Satoru
Hashimoto, Hiromasa
机构：
[1] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5091125, Japan
[2] Japan Tobacco Inc, Pharmaceut Frontier Res Labs, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 24期
关键词：
D O I：
10.1021/jm0610245
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H- benzo[5,6][1,4] diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.
引用
收藏
页码：6950 / 6953
页数：4
相关论文
共 24 条
  • [1] AFDHAL N, 2005, 40 EASL PAR FRAND AP
  • [2] Beaulieu P. L., 2003, Int. Patent Appl., Patent No. [WO 03010140, 03010140]
  • [3] Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: Inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells
    Beaulieu, PL
    Bousquet, Y
    Gauthier, J
    Gillard, J
    Marquis, M
    McKercher, G
    Pellerin, C
    Valois, S
    Kukolj, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) : 6884 - 6892
  • [4] Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase:: discovery and preliminary SAR of benzimidazole derivatives
    Beaulieu, PL
    Bös, M
    Bousquet, Y
    Fazal, G
    Gauthier, J
    Gillard, J
    Goulet, S
    LaPlante, S
    Poupart, MA
    Lefebvre, S
    McKercher, G
    Pellerin, C
    Austel, V
    Kukolj, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 119 - 124
  • [5] CHANDRA C, 2006, DDW 2006 LOS ANG MAY
  • [6] CONTE I, 2006, Patent No. 2006046030
  • [7] COULOMBE R, 2004, Patent No. 2004099241
  • [8] Challenges and successes in developing new therapies for hepatitis C
    De Francesco, R
    Migliaccio, G
    [J]. NATURE, 2005, 436 (7053) : 953 - 960
  • [9] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982
  • [10] Control of hepatitis C: A medicinal chemistry perspective
    Gordon, CP
    Keller, PA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) : 1 - 20
123